01—Abstract
Summary
Summary of the 8-K filed January 29, 2026. Cited figures are marked; the original filing is the authoritative source.
Dow Inc. reported a weak fourth quarter 2025 with net sales of $9.5 billiona, down 9% year-over-year and 5% sequentially, driven by price declines (local price down 8%) and softer volumes (down 2%).
Operating EBIT fell to $33 millionb from $454 million a year earlier, and GAAP results were a net loss of $1.5 billion ($2.15 per share). Operating EPS was a loss of $0.34, compared with breakeven in the prior-year quarter. The GAAP loss was driven by significant items totaling $1.81 per share, chiefly a $690 million goodwill impairment tied to the Polyurethanes & Construction Chemicals business, $303 million in asset-related charges, and $323 million in non-cash pension settlement charges.
For full year 2025, Dow posted net sales of $40.0 billionc, a GAAP net loss of $2.4 billion (versus $1.2 billion of income in 2024), and Operating EBIT of $0.4 billion, down from $2.6 billion. Operating cash flow from continuing operations was $1.1 billion, down from $2.9 billion, and free cash flow was negative $1.4 billion after $2.5 billion of capital expenditures. Dow paid $1.5 billion in dividends during the year.
Management highlighted progress on its cost reduction program, with over $400 milliond of accelerated savings from a $1 billion program, and launched "Transform to Outperform," which it expects to deliver at least $2 billion in additional near-term earnings. For investors, the key issues are the continued margin compression across the portfolio, the sizable impairments that signal weaker long-term expectations for certain assets, and the negative free cash flow that places pressure on the dividend and balance sheet. Net debt-related figures were not disclosed in this filing, and the $2 billion earnings target is a management expectation rather than guidance with a stated timeline, so investors should weigh it against the execution risk.
02—Key points
Key Highlights
- Q4 2025 net sales of $9.46 billion, down 9% year-over-year, with local price down 8% and volume down 2%, led by Packaging & Specialty Plastics.
- Q4 Operating EBIT of $33 million versus $454 million a year ago; Operating EBITDA of $741 million versus $1.2 billion.
- GAAP net loss of $1.48 billion (-$2.15 per share), driven by $1.81 per share in significant items including a $690 million goodwill impairment for Polyurethanes & Construction Chemicals and $323 million in non-cash pension settlement charges.
- Operating EPS was a loss of $0.34 in Q4 versus breakeven a year earlier; Industrial Intermediates & Infrastructure posted a $201 million operating EBIT loss.
- Full-year 2025 net sales of $40.0 billion, GAAP net loss of $2.4 billion, and Operating EBIT of $422 million versus $2.6 billion in 2024.
- Free cash flow was negative $1.4 billion for 2025 (operating cash flow of $1.1 billion less $2.5 billion in capex), while dividends paid totaled $1.5 billion.
- Management launched "Transform to Outperform" and expects at least $2 billion in additional near-term earnings from simplification and productivity efforts, on top of the $1 billion cost program.
03—Questions
Frequently Asked Questions
Why did Dow report a GAAP net loss in Q4 2025 when operating results were close to breakeven?
The GAAP loss was driven by significant items totaling $1.81 per share (about $1.3 billion after tax). The largest were a $690 million goodwill impairment tied to the Polyurethanes & Construction Chemicals business, $303 million in asset-related charges for Latin America chlor-alkali, propylene oxide and brine assets, $323 million in non-cash pension settlement charges, and $41 million in severance and related restructuring costs. Excluding these items, Operating EPS was a loss of $0.34.
Is Dow's cash flow sufficient to cover its dividend?
Not on a free cash flow basis in 2025. Operating cash flow from continuing operations was $1.06 billion against $2.48 billion of capital expenditures, producing negative free cash flow of $1.42 billion. Dividends paid were $1.49 billion for the year, so the shortfall was funded from other sources. The filing shows that 2025 financing inflows included $2.9 billion from the sale of noncontrolling interests and $2.8 billion in new long-term debt proceeds. Cash rose to $3.8 billion at year-end, up from $2.2 billion.
What are the main drivers of Dow's earnings weakness?
The primary driver is price. Local price fell 8% year-over-year in Q4 and 7% for full-year 2025, reflecting lower downstream polymer prices and weak industry conditions. Lower operating rates and margin compression, particularly in MEG at the Kuwait joint ventures, also weighed on results. Packaging & Specialty Plastics was affected by the idling of a cracker in EMEAI earlier in 2025, which reduced merchant olefins volumes. Partial offsets came from fixed-cost reductions and cost-program savings.
What is Transform to Outperform, and how much earnings improvement is expected?
Transform to Outperform is management's program to radically simplify Dow's operating model, reduce complexity, adopt best available technologies and streamline end-to-end processes. Management expects it to deliver at least $2 billion of additional near-term earnings and step-change productivity gains. The filing does not provide a specific timeline, cost to achieve, or formal guidance, so the target should be viewed as a management expectation subject to execution risk. It builds on the existing $1 billion cost program, of which more than $400 million was delivered in 2025.
Did the impairments signal anything about Dow's long-term outlook?
The $690 million goodwill impairment for Polyurethanes & Construction Chemicals and the $303 million asset charge for Latin American chlor-alkali, propylene oxide and brine assets indicate that management now sees lower future cash flows from these businesses than previously projected. Full-year 2025 restructuring, goodwill impairment and asset-related charges totaled $1.86 billion on the income statement. These are non-cash in nature, so they do not directly affect near-term cash, but they reduce book equity and signal weaker expected returns on the affected assets.
04—Continue